SOAR Program for Preventing Osteoarthritis After ACL Tear
(SOAR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a virtual education and exercise program, called Stop OsteoARthritis (SOAR), can improve knee health and prevent osteoarthritis in individuals who tore their ACL and underwent surgery 9 to 36 months ago. Participants will be randomly assigned to either the SOAR program or a minimal intervention control program to assess which is more effective in reducing knee pain and improving function and quality of life. Researchers will use MRIs to examine knee cartilage and evaluate the cost-effectiveness of the SOAR program. Individuals who experienced an ACL tear and surgery within the last 36 months and are not currently receiving knee care might be suitable for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance knee health for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the SOAR program is safe for preventing osteoarthritis after ACL tear?
Research shows that the Stop OsteoARthritis (SOAR) program, which includes online learning and exercise therapy, is generally easy for participants to handle. Studies on similar programs have found that people often experience stronger knees and improved knee health without major side effects. Although specific safety data for the SOAR program is not available, its focus on exercise and education is considered low-risk. Exercise therapy is a common and safe method used in physical rehabilitation. Overall, evidence suggests that the SOAR program should be safe for most people, especially since it uses well-known methods for improving knee health after injuries.12345
Why are researchers excited about this trial?
Researchers are excited about the SOAR program because it offers a comprehensive approach to preventing osteoarthritis after an ACL tear, which current standard care options, like surgery and physical therapy, don’t specifically address long-term joint health. The SOAR program combines a unique blend of interventions, including a one-time Knee Camp, consistent home-based exercise therapy, and regular physiotherapist guidance, tailored to each participant's needs. This integrated approach not only aims to improve recovery outcomes but also actively targets the prevention of osteoarthritis, potentially changing the trajectory of joint health after ACL injuries.
What evidence suggests that the SOAR program is effective for preventing osteoarthritis after an ACL tear?
Research has shown that the Stop OsteoARthritis (SOAR) program, which participants in this trial may receive, can improve knee health in individuals who have had ACL tears and surgery. A previous study found the SOAR program more effective in boosting knee strength and reducing symptoms compared to minimal activity. Participants reported better knee health after completing the program's exercise and education sessions. The program emphasizes exercises and education to prevent worsening knee problems, potentially lowering the risk of developing osteoarthritis. Early findings suggest this approach could maintain knee function and enhance quality of life.14678
Who Is on the Research Team?
Jackie L Whittaker, BScPT, PhD
Principal Investigator
University of British Columbia
Are You a Good Fit for This Trial?
This trial is for young adults aged 16-35 in British Columbia who had ACL reconstruction surgery 9-36 months ago. Participants should not be currently receiving other knee treatments, have limited knee function as measured by a KOOS4 score, and must have daily internet access to participate in virtual programs.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-month virtual education and exercise therapy program called Stop OsteoARthritis (SOAR) or a minimal intervention control program
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6, 12, and 24 months
MRI Assessment
MRI assessments to evaluate knee cartilage degeneration and other OA features
What Are the Treatments Tested in This Trial?
Interventions
- Stop OsteoARthritis (SOAR) program
Trial Overview
The study compares the SOAR program—a virtual education and exercise therapy—with a minimal intervention control program for improving knee health post-ACL tear. It measures pain relief, symptom improvement, better function, quality of life over time, and uses MRIs to check cartilage changes.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants with a first-time ACL tear followed by reconstruction surgery randomized to the SOAR program group will complete a 6-month SOAR program (one-time Knee Camp, weekly home-based exercise therapy and physical activity with tracking, weekly 1:1 physiotherapist counseling sessions, and optional weekly group-based exercise classes) Consented trained physiotherapists will deliver the SOAR program throughout the study period to one or more SOAR program participants. Physiotherapists and SOAR participants will be randomly paired.
Participants with a first-time ACL tear followed by reconstruction surgery randomized to the minimal control (Living Well after ACLR) group will complete a 6-month minimal intervention control program (educational video, workbook, activity tracking, and one 1:1 physiotherapist counseling session).
Stop OsteoARthritis (SOAR) program is already approved in Canada for the following indications:
- Prevention of osteoarthritis after ACL reconstruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Arthritis Research Centre of Canada
Collaborator
The Arthritis Society, Canada
Collaborator
Published Research Related to This Trial
Citations
Assessing the efficacy of the Stop OsteoARthritis (SOAR) ...
The primary outcome was a change in isokinetic knee extensor strength (baseline to 9-weeks). Additional outcomes included change in self-reported knee-related ...
Digital education and exercise therapy versus minimal ...
This study will assess if a digital education and exercise therapy intervention is superior to minimal intervention for improving knee-related symptoms, ...
Feasibility of the SOAR (Stop OsteoARthritis) program - PMC
A strength of the study is that we have demonstrated the feasibility of the SOAR program with persons who have a wide range of time loss, ...
A RANDOMIZED DELAYED-CONTROLLED TRIAL FOR ...
This study aims to: i) describe 11-year outcomes and radiographic osteoarthritis. (ROA) by 5-year ACL continuity status, and ii) investigate the relationship.
5.
trialsjournal.biomedcentral.com
trialsjournal.biomedcentral.com/articles/10.1186/s13063-025-08896-6Digital education and exercise therapy versus minimal ... - Trials
The Stop OsteoARthritis (SOAR) study is a parallel, two-arm, assessor-blinded, superiority, hybrid effectiveness-implementation type 1 ...
Digital education and exercise therapy versus minimal ...
Digital education and exercise therapy versus minimal intervention for young people at high risk of early onset knee osteoarthritis after ACL reconstruction.
Evidence Review for Preventing Osteoarthritis After an ...
Evidence review for preventing osteoarthritis after an anterior cruciate ligament injury: An Osteoarthritis Action Alliance consensus statement.
2-Year Injury Rates in the ACL-SPORTS Randomized ...
There were 9 second ACL injuries in the 2 years after ACLR. There was no statistically significant difference in rate or side of second ACL ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.